The treatment involves drawing a blood sample, processing it to concentrate the platelets, and injecting the platelet-rich plasma into the affected joint
It was added to the Prohibited List in 2022 as a non-approved substance, reflecting its transition from an obscure research compound to a significant "substance of interest" in professional athletics
The operation time is minimal, as no injections or surgical intervention are required for standard capsule-based therapy
An increasing number of viewpoints now suggest that diabetic retinopathy is not merely a vascular complication but rather a neurovascular disorder
Researchers often study GHK-CU for its potential relevance to: Collagen-related signaling Tissue remodeling Skin regeneration support Fibroblast activity Extracellular matrix regulation Anti-inflammatory and antioxidant pathways Several published studies have associated GHK and GHK-CU with tissue repair, skin remodeling, and regenerative biological pathways
BPC 157 , a synthetic peptide, has emerged as a subject of growing interest in the UK athletic community